New Hope for Patients with Metastatic Triple-Negative Breast Cancer: Antibody Drug Conjugate Doubles Survival Time for Some Patients

Published Apr 23, 2021

New Hope for Patients with Metastatic Triple-Negative Breast Cancer: Antibody Drug Conjugate Doubles Survival Time for Some Patients

NOW
PLAYING
Sofia Vergara Beat Thyroid Cancer; New Research Suggests Continued Overdiagnosis Of This Disease
NOW
PLAYING
'Wicked' Actress, 39, Says 'I Have No Hair, But I Still Have My Spirit & My Joy' -- Kara Lindsay Determined To Beat Breast Cancer
NOW
PLAYING
Should People With Cancer Avoid Cats? The Link To Parasitic Infection And How To Protect Yourself
NOW
PLAYING
'Come On Down' For Awesome News! Utah Woman Goes on The 'Price is Right' To Announce She is Cancer Free
NOW
PLAYING
Country Singer Morgan Wade, 29, Is Touring With Her Sweet French Bulldog 'Chop' After Preventative Breast Removal Surgery— The Power of Pet Therapy
NOW
PLAYING
New CML Approval: Leading Leukemia Expert on the 'Significant Improvement' Asciminib (Scemblix) Offers as a First-Line Treatment Option

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

AI-Powered by My Health Questions

Built by medical professionals

Want to dive deeper into this article?

Try asking any of the questions below:

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... breast cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider